CDKN1A and glioblastoma: We speculate that since CDKN1A was significantly correlated with various types of tumor-infiltrating lymphocytes, immunoinhibitors, immunostimulators and MHC molecules in GBM, it might exert a more significant effect on immune fingerprinting in GBM.